The Watchman FLX - a New Device for Left Atrial Appendage Occlusion - Design, Potential Benefits and First Clinical Experience

Overview

Journal Postepy Kardiol Interwencyjnej

Publisher Termedia

Specialty Cardiology & Vascular Diseases

Date 2017 Mar 28

PMID 28344619

Citations 11

Authors

Marek Grygier

Anna Olasinska-Wisniewska

Aleksander Araszkiewicz

Olga Trojnarska

Anna Babicz-Sadowska

Maciej Lesiak

Affiliations

Soon will be listed here.

Citing Articles

Quantitative considerations for choosing between Amulet and Watchman FLX and management of device related complications.

Kushnir A, Barbhaiya C, Jankelson L, Holmes D, Aizer A, Park D J Interv Card Electrophysiol. 2025; .

PMID: 39939509 DOI: 10.1007/s10840-025-02011-0.

A Comprehensive Review of Percutaneous and Surgical Left Atrial Appendage Occlusion.

Swieczkowski M, Dabrowski E, Muszynski P, Pogorzelski P, Jemielita P, Dudzik J J Cardiovasc Dev Dis. 2024; 11(8).

PMID: 39195142 PMC: 11354510. DOI: 10.3390/jcdd11080234.

Device-Associated Thrombus with Watchman FLX Left Atrial Appendage Closure Device: A Report of Two Cases.

Dhaduk N, Vainrib A, Bamira D, Ro R, Aizer A, Chinitz L CASE (Phila). 2023; 7(6):226-232.

PMID: 37396475 PMC: 10307589. DOI: 10.1016/j.case.2023.01.010.

Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry.

Berti S, De Caterina A, Grasso C, Casu G, Giacchi G, Pagnotta P Front Cardiovasc Med. 2023; 10:1115811.

PMID: 37180775 PMC: 10172664. DOI: 10.3389/fcvm.2023.1115811.

WATCHMAN FLX implantation with an extremely small left atrial appendage ostium.

Yano M, Egami Y, Nishino M, Tanouchi J Eur Heart J Case Rep. 2022; 6(2):ytac090.

PMID: 35295726 PMC: 8922692. DOI: 10.1093/ehjcr/ytac090.

References

Holmes Jr D, Kar S, Price M, Whisenant B, Sievert H, Doshi S . Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014; 64(1):1-12. DOI: 10.1016/j.jacc.2014.04.029. View

Reddy V, Holmes D, Doshi S, Neuzil P, Kar S . Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011; 123(4):417-24. DOI: 10.1161/CIRCULATIONAHA.110.976449. View

Lam S, Bertog S, Gafoor S, Vaskelyte L, Boehm P, Ho R . Left atrial appendage closure using the Amulet device: an initial experience with the second generation amplatzer cardiac plug. Catheter Cardiovasc Interv. 2014; 85(2):297-303. DOI: 10.1002/ccd.25644. View

Reddy V, Mobius-Winkler S, Miller M, Neuzil P, Schuler G, Wiebe J . Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol. 2013; 61(25):2551-6. DOI: 10.1016/j.jacc.2013.03.035. View

Reddy V, Doshi S, Sievert H, Buchbinder M, Neuzil P, Huber K . Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013; 127(6):720-9. DOI: 10.1161/CIRCULATIONAHA.112.114389. View